Filing Details

Accession Number:
0000899243-21-002559
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-20 20:00:08
Reporting Period:
2021-01-15
Accepted Time:
2021-01-20 20:00:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1351288 Gw Pharmaceuticals Plc GWPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1754239 D. Adam George Sovereign House, Vision Park, Histon
Cambridge X0 CB24 9BZ
Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2021-01-15 25,716 $10.61 35,716 No 4 M Direct
Ordinary Shares Acquisiton 2021-01-15 52,560 $9.81 88,276 No 4 M Direct
Ordinary Shares Acquisiton 2021-01-15 1,584 $9.61 89,860 No 4 M Direct
Ordinary Shares Disposition 2021-01-15 53,376 $11.72 36,484 No 4 S Direct
Ordinary Shares Disposition 2021-01-15 26,484 $11.75 10,000 No 4 S Direct
Ordinary Shares Acquisiton 2021-01-19 9,600 $9.61 19,600 No 4 M Direct
Ordinary Shares Disposition 2021-01-19 9,600 $11.68 10,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Options Disposition 2021-01-15 25,716 $0.00 25,716 $10.61
Ordinary Shares Share Options Disposition 2021-01-15 52,560 $0.00 52,560 $9.81
Ordinary Shares Share Options Disposition 2021-01-15 1,584 $0.00 1,584 $9.61
Ordinary Shares Share Options Disposition 2021-01-15 9,600 $0.00 9,600 $9.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4 2018-06-24 2025-06-24 No 4 M Direct
0 2020-01-06 2027-01-06 No 4 M Direct
48,888 2020-12-31 2028-02-26 No 4 M Direct
39,288 2020-12-31 2028-02-26 No 4 M Direct
Footnotes
  1. Exercise of share options. Following the exercise, these shares were converted into American Depositary Shares of ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
  2. The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.
  3. Represented by ADSs.
  4. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($140.67 per ADS). These shares were sold in multiple transactions at prices ranging from $140.00 per ADS (or $11.67 per ordinary share) to $140.87 per ADS (or $11.74 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($141.04 per ADS). These shares were sold in multiple transactions at prices ranging from $141.11 per ADS (or $11.76 per ordinary share) to $141.61 per ADS (or $11.80 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($140.15 per ADS). These shares were sold in multiple transactions at prices ranging from $140.04 per ADS (or $11.67 per ordinary share) to $140.83 per ADS (or $11.74 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. Accelerated due to retirement of the reporting person.